Hopkinson Craig C.
EVP R&D, Chief Medical Officer · 34 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | ALKS | Alkermes plc. | Sale | 8,300 | $51.46 | $427,128.79 | filing |
| 2026-07-01 | ALKS | Alkermes plc. | Option exercise | 5,000 | $19.34 | $96,700.00 | filing |
| 2026-07-01 | ALKS | Alkermes plc. | Sale | 700 | $52.13 | $36,491.98 | filing |
| 2026-06-01 | ALKS | Alkermes plc. | Sale | 9,000 | $41.67 | $375,043.50 | filing |
| 2026-06-01 | ALKS | Alkermes plc. | Option exercise | 5,000 | $19.34 | $96,700.00 | filing |
| 2026-05-01 | ALKS | Alkermes plc. | Sale | 9,000 | $33.40 | $300,559.50 | filing |
| 2026-05-01 | ALKS | Alkermes plc. | Option exercise | 5,000 | $19.34 | $96,700.00 | filing |
| 2026-04-01 | ALKS | Alkermes plc. | Sale | 9,000 | $35.51 | $319,604.40 | filing |
| 2026-04-01 | ALKS | Alkermes plc. | Option exercise | 5,000 | $19.34 | $96,700.00 | filing |
| 2026-03-02 | ALKS | Alkermes plc. | Sale | 9,000 | $29.72 | $267,485.40 | filing |
| 2026-03-02 | ALKS | Alkermes plc. | Option exercise | 5,000 | $19.34 | $96,700.00 | filing |
| 2026-02-26 | ALKS | Alkermes plc. | Tax withholding | 3,049 | $30.73 | $93,695.77 | filing |
| 2026-02-26 | ALKS | Alkermes plc. | Option exercise | 6,866 | — | — | filing |
| 2026-02-23 | ALKS | Alkermes plc. | Tax withholding | 3,414 | $32.19 | $109,896.66 | filing |
| 2026-02-23 | ALKS | Alkermes plc. | Option exercise | 7,689 | — | — | filing |
| 2026-02-19 | ALKS | Alkermes plc. | Tax withholding | 3,407 | $32.00 | $109,024.00 | filing |
| 2026-02-19 | ALKS | Alkermes plc. | Option exercise | 7,673 | — | — | filing |
| 2026-02-18 | ALKS | Alkermes plc. | Tax withholding | 3,504 | $32.02 | $112,198.08 | filing |
| 2026-02-18 | ALKS | Alkermes plc. | Option exercise | 8,897 | — | — | filing |
| 2026-02-05 | ALKS | Alkermes plc. | Tax withholding | 7,454 | $33.55 | $250,081.70 | filing |
| 2026-02-05 | ALKS | Alkermes plc. | Award | 25,352 | — | — | filing |
| 2026-02-02 | ALKS | Alkermes plc. | Sale | 5,000 | $34.24 | $171,224.50 | filing |
| 2026-02-02 | ALKS | Alkermes plc. | Sale | 4,000 | $33.54 | $134,160.00 | filing |
| 2026-02-02 | ALKS | Alkermes plc. | Option exercise | 5,000 | $19.34 | $96,700.00 | filing |
| 2026-01-08 | ALKS | Alkermes plc. | Sale | 5,000 | $30.00 | $150,005.00 | filing |
| 2026-01-08 | ALKS | Alkermes plc. | Option exercise | 5,000 | $19.34 | $96,700.00 | filing |
| 2026-01-02 | ALKS | Alkermes plc. | Sale | 4,000 | $28.00 | $112,000.00 | filing |
| 2025-12-03 | ALKS | Alkermes plc. | Sale | 3,748 | $30.00 | $112,447.12 | filing |
| 2025-12-03 | ALKS | Alkermes plc. | Option exercise | 3,748 | $19.34 | $72,486.32 | filing |
| 2025-12-01 | ALKS | Alkermes plc. | Sale | 4,000 | $29.30 | $117,200.00 | filing |
| 2025-11-03 | ALKS | Alkermes plc. | Sale | 9,000 | $30.38 | $273,441.60 | filing |
| 2025-11-03 | ALKS | Alkermes plc. | Option exercise | 5,000 | $19.34 | $96,700.00 | filing |
| 2025-10-15 | ALKS | Alkermes plc. | Sale | 9,000 | $31.53 | $283,776.30 | filing |
| 2025-10-15 | ALKS | Alkermes plc. | Option exercise | 5,000 | $19.34 | $96,700.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.